Just wondering - Since we as yet have not gotten confirmation that COHORT 4 has started. Is it possible that DF is trying to get FDA approval to have that group allowed to be larger than what was planned ? After all if something was amiss the study would have been stopped, but maybe they want to enlarge the group size to better confirm what they are finding. Is this a possibility ?